Search
Results: 10
Determining the Best Immunization Strategy for Protecting African Children Against Invasive Salmonella Disease.
Hyon Jin Jeon, Gi Deok Pak, Justin Im, Ellis Owusu-Dabo, Yaw Adu-Sarkodie, Amy Gassama Sow, Abdramane Bassiahi Soura, Nagla Gasmelseed, Karen H Keddy, Morten Bjerregaard-Andersen, Frank Konings, Abraham Aseffa, John A Crump, Yun Chon, Robert F Breiman, Se Eun Park, Ligia Maria Cruz Espinoza, Hye Jin Seo, Jürgen May, Christian G Meyer, Jason R Andrews, Ursula Panzner, Vera von Kalckreuth, Thomas F Wierzba, Raphaël Rakotozandrindrainy, Gordon Dougan, Myron M Levine, Joachim Hombach, Jerome H Kim, John D Clemens, Stephen Baker, Florian Marks
Sep 10, 2018
BACKGROUND: The World Health Organization recently prequalified a typhoid conjugate vaccine (TCV), recommending its use in persons ≥6 months to 45 years residing in typhoid fever (TF)-endemic areas. We now need to consider how...
Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger
SM Niaz Arifin, Christoph Zimmer, Caroline Trotter, Anaïs Colombini, Fati Sidikou, F Marc LaForce, Ted Cohen, Reza Yaesoubi
Jun 28, 2019
Structure of a protective epitope reveals the importance of acetylation of Neisseria meningitidis serogroup A capsular polysaccharide.
Pedro Henriques, Lucia Dello Iacono, Ana Gimeno, Alessia Biolchi, Maria Rosaria Romano, Ana Arda, Gonҫalo JL Bernardes, Jesus Jimenez-Barbero, Francesco Berti, Rino Rappuoli, Roberto Adamo
Nov 16, 2020
Meningococcal meningitis remains a substantial cause of mortality and morbidity worldwide. Until recently, countries in the African meningitis belt were susceptible to devastating outbreaks, largely attributed to serogroup A...
Neisseria meningitidis Carbohydrates structural glycobiology vaccines Acetylation Adolescent Antibodies Bacterial Child Clinical Trials Phase II as Topic Crystallography X-Ray Epitopes Female Humans Immunogenicity Vaccine Immunoglobulin Fab Fragments Male Meningitis Meningococcal Meningococcal Vaccines Molecular Docking Simulation Multicenter Studies as Topic Neisseria meningitidis Polysaccharides Bacterial Randomized Controlled Trials as Topic Serogroup Serum Bactericidal Antibody Assay vaccines Conjugate
The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso
Reza Yaesoubi, Caroline Trotter, Caroline Colijn, Maziar Yaesoubi, Anaïs Colombini, Stephen Resch, Paul A Kristiansen, F Marc LaForce, Ted Cohen
Feb 27, 2018
BACKGROUND: The introduction of a conjugate vaccine for serogroup A Neisseria meningitidis has dramatically reduced disease in the African meningitis belt. In this context, important questions remain about the performance of...
Typhoid conjugate vaccines
Jason R Andrews, Stephen Baker, Florian Marks, Marcella Alsan, Denise Garrett, Bruce G Gellin, Samir K Saha, Farah Naz Qamar, Mohammad Tahir Yousafzai, Isaac I Bogoch, Marina Antillon, Virginia E Pitzer, Jong-Hoon Kim, Jacob John, Jillian Gauld, Vittal Mogasale, Edward T Ryan, Stephen P Luby, Nathan C Lo
Aug 01, 2019
Typhoid fever is an acute systemic infectious disease responsible for an estimated 12-20 million illnesses and over 150 000 deaths annually. In March, 2018, a new recommendation was issued by WHO for the programmatic use of...
The Global Meningococcal Initiative
Ray Borrow, Pedro Alarcón, Josefina Carlos, Dominique A Caugant, Hannah Christensen, Roberto Debbag, Philippe De Wals, Gabriela Echániz-Aviles, Jamie Findlow, Chris Head, Daphne Holt, Hajime Kamiya, Samir K Saha, Sergey Sidorenko, Muhamed-Kheir Taha, Caroline Trotter, Julio A Vázquez Moreno, Anne von Gottberg, Marco AP Sáfadi, Global Meningococcal Initiative
Jan 31, 2017
EPIDEMIOLOGY Global Meningococcal Initiative MenW Neisseria meningitidis Meningococcal disease outbreaks Prevention serogroups SURVEILLANCE Vaccination Disease Outbreaks Global Health Humans Immunization Programs Incidence Meningitis Meningococcal Meningococcal Infections Meningococcal Vaccines Neisseria meningitidis vaccines Conjugate
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults
Hannah Lawrence, Harry Pick, Vadsala Baskaran, Priya Daniel, Chamira Rodrigo, Deborah Ashton, Rochelle C Edwards-Pritchard, Carmen Sheppard, Seyi D Eletu, David Litt, Norman K Fry, Samuel Rose, Caroline Trotter, Tricia M Mckeever, Wei Shen Lim
Nov 09, 2020
BACKGROUND: Vaccination with the 23-valent pneumococcal polysaccharide vaccine (PPV23) is available in the United Kingdom to adults aged 65 years or older and those in defined clinical risk groups. We evaluated the vaccine...
Adult Aged Aged 80 and over Case-Control Studies Community-Acquired Infections Female Hospitalization Humans Male Middle Aged Odds Ratio Pneumococcal Infections Pneumococcal Vaccines Pneumonia Pneumococcal Prospective Studies Serogroup Streptococcus pneumoniae United Kingdom Vaccination vaccines Conjugate
Meningococcal carriage in the African meningitis belt.
MenAfriCar consortium
Jan 23, 2018
A meningococcal serogroup A polysaccharide/tetanus toxoid conjugate vaccine (PsA-TT) (MenAfriVac(™) ) is being deployed in countries of the African meningitis belt. Experience with other polysaccharide/protein conjugate vaccines...
Africa MenAfriCar Neisseria meningitidis meningococcal carriage Meningococcal Vaccines meningococcus Adolescent Adult Africa Carrier State Child Child Preschool Cross-Sectional Studies Enzyme-Linked Immunosorbent Assay Epidemics Humans Immunization Programs Infant International Cooperation Meningitis Meningococcal Meningococcal Vaccines Neisseria meningitidis Serogroup A Pharynx Pilot Projects Polymerase Chain Reaction Program Evaluation Specimen Handling vaccines Conjugate Young Adult
The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs
Typhoid fever is estimated to cause between 11.9-26.9 million infections globally each year with 129,000-216,510 deaths. Access to improved water sources have reduced disease incidence in parts of the world but the use of...